---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-25-051124"
form_type: "8-K"
ticker: null
cik: "0001463361"
company_name: "Unity Biotechnology, Inc."
filed_at: "2025-04-04T23:59:59+00:00"
generated_at: "2026-05-23T20:52:29.221148+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Unity Biotechnology board member Paul L. Berns resigns effective April 4, 2025

## Summary
- Paul L. Berns resigned from Unity's Board and all committees effective April 4, 2025.
- Resignation was not due to any dispute or disagreement with the company.
- No replacement named; board size reduced accordingly.

## SEC filing metadata
- accession: 0000950170-25-051124
- form_type: 8-K
- cik: 0001463361
- company_name: Unity Biotechnology, Inc.
- filed_at: 2025-04-04T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1463361/000095017025051124/0000950170-25-051124-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1463361/000095017025051124/ubx-20250403.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-25-051124
- JSON: https://secwatch.observer/filing/0000950170-25-051124.json
- Plain text: https://secwatch.observer/filing/0000950170-25-051124.txt

## Key facts
- Executive change
  Paul L. Berns resigned as Director at Unity Biotechnology, Inc..
  - Action: resigned
  - Role: Director
  source text: On April 3, 2025, Paul L. Berns informed the Board of Directors (the “Board”) of UNITY Biotechnology, Inc. (“Unity” or the “Company”) of his resignation as a member of the Board of the Company, and all of the committees of the Board on which he serves, in each case, effective at the close of business on April 4, 2025.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1463361/000095017025051124/0000950170-25-051124-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.